SCHEMBL1279264

SCHEMBL1279264

O=c1cc(-c2cc(F)c(F)cc2F)[nH]c2c(-c3ccccc3)c(C(F)(F)F)nn12

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ARF6 P62330 7/20 0.45
POLB P06746 4/20 0.40
KDM4E B2RXH2 2/20 0.40
KCNQ3 O43525 7/20 0.40
KCNQ2 O43526 7/20 0.40
KCNQ1 P51787 1/20 0.39
PLAT P00750 1/20 0.38
ALDH1A1 P00352 2/20 0.37
JAK2 O60674 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
TYK2 P29597 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1279231 0.90 ARF6 (0.38) ARF6POLBKDM4EKCNQ3KCNQ2
SCHEMBL1278555 0.89 KCNQ3 (0.50) ARF6POLBKDM4EKCNQ3KCNQ2
SCHEMBL1286604 0.87 ARF6 (0.47) ARF6POLBKDM4EKCNQ3KCNQ2
SCHEMBL10062354 0.86 KCNQ3 (0.54) ARF6POLBKDM4EKCNQ3KCNQ2
SCHEMBL1279244 0.84 KCNQ3 (0.42) ARF6KDM4EKCNQ3KCNQ2GAA
SCHEMBL1614789 0.84 MAPT (0.36) KDM4EPLATALDH1A1MEN1KMT2A
SCHEMBL1278995 0.83 KCNQ3 (0.41) ARF6KDM4EKCNQ3KCNQ2ALDH1A1
SCHEMBL1278782 0.81 ARF6 (0.58) ARF6POLBKDM4EKCNQ3KCNQ2
SCHEMBL1279157 0.80 ARF6 (0.47) ARF6POLBKDM4EKCNQ3KCNQ2
SCHEMBL1278581 0.79 KCNQ3 (0.52) ARF6POLBKCNQ3KCNQ2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 ARF6 3851/4885POLB 2845/4885KDM4E 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.